SheriseChantellRogersMDMPH

PubMed

• Development of novel pyrimidine nucleoside analogs as potential anticancer agents: Synthesis, characterization, and In-vitro evaluation against pancreatic cancer.
  Esther Frimpong, Raviteja Bulusu, Joy Okoro, Andriana Inkoom, Nkafu Ndemazie, Xue Zhu, Bo Han, Edward Agyare, Sherise Rogers> ;European Journal of Pharmaceutical Sciences. 2024 May 1
• Complete clinical remission of malignant peritoneal mesothelioma with systemic pemetrexed and bevacizumab in a patient with a BAP1 mutation.
  Lee, J., Turetsky, J., Nasri, E., Rogers, S.> ;BMJ Case Reports. 2023 Dec 23
• Addendum: Importance of carbohydrate antigen (CA 19-9) and carcinoembrionic antigen (CEA) in the prognosis of patients with duodenal adenocarcinoma: a retrospective si...
  Hones, K., Leach, D., Ellery Altshuler, Raymond Richhart, William King, Mahmoud Aryan, Akash Mathavan, Akshay Mathavan, Keegan Hones, Daniel F Leach 3rd, Logan Pucci, ...> ;Oncotarget. 2023 Dec 12
• The Prospect of Harnessing the Microbiome to Improve Immunotherapeutic Response in Pancreatic Cancer.
  Sherise Rogers, Angel Charles, Ryan M Thomas> ;Cancers. 2023 Dec 5
• Unraveling Racial Disparities in Supportive Care Medication Use among End-of-Life Pancreatic Cancer Patients: Focus on Pain Management and Psychiatric Therapies.
  John M Allen, MegCholack Awunti, Yi Guo, Jiang Bian, Sherise C Rogers, Lisa Scarton, David L DeRemer, Diana J Wilkie> ;Cancer Epidemiology, Biomarkers & Prevention. 2023 Dec 1
• 1 citations
  Prognosis and Treatment Outcomes of Bone Metastasis in Gallbladder Adenocarcinoma: A SEER-Based Study.
  Kriti Gera, Doga Kahramangil, Graeme A Fenton, Daniela Martir, Zohaib Ijaz, Sherise C Rogers, Brian H Ramnaraign, Thomas J George, Young-Rock Hong, Steven J Hughes, Ib...> ;Cancers. 2023 Oct 19
• A phase II study of neoadjuvant liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in pancreatic adenocarcinoma.
  Ruchi Singhal, Sherise C Rogers, Ji-Hyun Lee, Brian Ramnaraign, Ilyas Sahin, Jesus C Fabregas, Ryan M Thomas, Steven J Hughes, Ibrahim Nassour, Kathryn Hitchcock, Kare...> ;Future Oncology. 2023 Sep 1
• 2 citations
  National adoption of neoadjuvant chemotherapy: paradigm shift in the treatment of pancreatic cancer.
  Ibrahim Nassour, Austin Parrish, Lucy Baptist, Sarah Voskamp, Komal Handoo, Sherise Rogers, Jesus Fabregas, Thomas George, Kathryn Hitchcock, Alessandro Paniccia, Stev...> ;HPB. 2023 Nov 1
• A nurse-led intervention in patients with newly diagnosed cancer and Type 2 diabetes: A pilot randomized controlled trial feasibility study.
  Lisa Scarton, Tarah Nelson, Ara Jo, LaToya J O'Neal, Yingwei Yao, Shavondra Huggins, Anatolia B Legaspi, Mariah J McClaren, Jake S Cabassa, Joan M Burgos Melendez, Jua...> ;Cancer Medicine. 2023 Jun 1
• Importance of carbohydrate antigen (CA 19-9) and carcinoembrionic antigen (CEA) in the prognosis of patients with duodenal adenocarcinoma: a retrospective single-insti...
  Hones, K., Altshuler, E., Richhart, R., King, W., Aryan, M., Mathavan, A., Mathavan, A., Hones, K., Leach, D., Pucci, L., Riklan, J., Haley, P., Sahin, I., Ramnaraign,...> ;Oncotarget. 2023 Apr 15
• 2 citations
  Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans.
  Guettchina Telisnor, David L DeRemer, Esther Frimpong, Edward Agyare, John Allen, Luisel Ricks-Santi, Bo Han, Thomas George, Sherise C Rogers> ;Journal of the National Medical Association. 2023 Apr 1
• Effects of Clinical and Tumor Characteristics on Survival in Patients with Hepatocellular Carcinoma with Bone Metastasis.
  Muhammet Ozer, Rick Y Lin, Doga Kahramangil, Sherise C Rogers, Jesus C Fabregas, Brian H Ramnaraign, Thomas J George, Michael Feely, Roniel Cabrera, Sergio Duarte, Ali...> ;Journal of Hepatocellular Carcinoma. 2023 Jan 1
• 1 citations
  A Scoping Review on the Relationship between Race/Ethnicity and the Receipt of Supportive Care Medications during Cancer Treatment: Implications for the Clinical Pharm...
  MegCholack Awunti, David L DeRemer, Sherise Rogers, Lisa Scarton, Lauren Adkins, Diana J WIlkie, John M Allen> ;Journal of the American College of Clinical Pharmacy. 2022 Dec 1
• Chemotherapy is associated with improved survival in a national cohort of stage IV pancreatic adenosquamous carcinoma.
  Ellery Altshuler, Andrea N Riner, Kelly M Herremans, Thomas J George, Sherise C Rogers, Alessandro Paniccia, Steven J Hughes, Jesus C Fabregas, Ibrahim Nassour> ;Journal of Gastrointestinal Oncology. 2022 Dec 1
• Atezolizumab plus tivozanib for immunologically cold tumor types: the IMMCO-1 trial.
  Brian H Ramnaraign, Ji-Hyun Lee, Azka Ali, Sherise C Rogers, Jesus C Fabregas, Ryan M Thomas, Carmen J Allegra, Ilyas Sahin, David L DeRemer, Thomas J George, Jonathan...> ;Future Oncology. 2022 Nov 18
• 7 citations
  Immunotherapy Management in Special Cancer Patient Populations.
  Brian Hemendra Ramnaraign, Jonathan Alexander Chatzkel, Zeina Al-Mansour, Sherise C. Rogers, Dennie Jones, David L. DeRemer, Thomas J. George> ;JCO Oncology Practice. 2021 Mar 12
• 4 citations
  Discontinuation of Everolimus Due to Related and Unrelated Adverse Events in Cancer Patients: A Meta-Analysis.
  Sherise Chantell Rogers, Christine A. Garcia, Shenhong Wu> ;Cancer Investigation. 2017 Aug 11
• 2 citations
  The First Case of HER2+ Invasive Ductal Carcinoma Arising From a Breast Hamartoma and Literature Review.
  Lea Baer, Sherise Chantell Rogers, Patricia Farrelly, Carmen Tornos, Keith Sweeney> ;Journal of the National Medical Association. 2017 Mar 1
• Join now to see all